Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
Clinical trial NCT03598309 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03598309
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-05
- Primary completion
- 2025-05-29
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.